Vireo Health Announces Name Change to Goodness Growth Holdings in Conjunction with 2021 Investor Day Events Management unveils its Horizon Strategy with outlook ranges for FY22 revenue and adjusted...
Vireo Health Announces First Quarter 2021 Financial Results — Q1 GAAP revenue of $13.2 million increased 9% compared to Q1 2020 — — Excluding former PA subsidiaries, Q1 revenue...
Vireo Health Closes First Tranche of Debt Financing with Green Ivy Capital Credit facility provides growth capital to expand first-mover advantage in Vireo’s core markets Company plans to begin...
Vireo Health Announces Fourth Quarter and Full Year 2020 Financial Results Full year GAAP revenue of $49.2 million increased 64% compared to full year 2019 Q4 GAAP revenue increased...
Vireo Health Announces Third Quarter 2020 Financial Results Total revenue of $13.4 million increased 68 percent year-over-year Gross margin of 42.7% reflects improving manufacturing efficiencies in core markets Christian...
Vireo Health Announces Forced Redemption of Warrants Issued in Conjunction with March 2020 Private Placement — Successful financing helped drive improvements in operating performance — — Management expects redemptions...
Vireo Health and Green Ivy Capital Agree to Proposed U.S. $46.0 Million Senior Secured Non-Convertible Credit Facility First tranche of U.S. $10.0 million net expected to close in December...
Vireo Health Announces Second Quarter 2020 Financial Results Total revenue of $12.2 million increased 70 percent year-over-year Operating cost structure continues to improve in-line with management’s expectations Development project...
Vireo Health Completes Sale of Equity in Pennsylvania Medical Solutions to Jushi Holdings Inc. for Total Consideration of $37 Million Transaction secures Vireo’s financial future without dilutive impacts to...
Vireo Health Announces Sale of Equity in Pennsylvania Medical Solutions to Jushi Holdings Inc. for Total Consideration of $37 Million Transaction secures Vireo’s financial future without dilutive impacts to...
Vireo Health Announces First Quarter 2020 Financial Results First-quarter revenue of $12.1 million increased 34% sequentially and 110% year-over-year Minimal capex requirements position Company for stronger second half compared...
Vireo Health Raises $10.5 Million to Increase Sales Volume and Margin CAD $10.5 million financing to increase retail sell through in key medical only markets Management provides update regarding recent strategic...
Vireo Health Names Bruce Linton as Executive Chairman MINNEAPOLIS, Nov. 7, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-led,...
Vireo Health Announces Second Quarter 2019 Financial Results – Total revenue of $7.2 million increased 70 percent year-over-year – Voluntary share lock-up extensions approved by management and insiders –...
Vireo Health Announces First Quarter 2019 Financial Results Pro forma Q1 revenue of approximately $7.0 million Total revenue of $5.8 million increased approximately 57 percent year-over-year Minnesota passes law...
Vireo Health Announces Full Year 2018 Revenues of $18.5 Million with 70% Year-Over-Year Growth Company raised $51.4 million through reverse takeover transaction (RTO) in March Successful closing of five...
